On September 14, Kairos Pharma issued a new investor presentation and made it available for publication on its website. CEO John Yu presented the material at the H.C. Wainwright conference to update investors on the company’s clinical program and activities, giving investors the stated venue for its latest clinical update.

Key Highlights

  • John Yu presented Kairos Pharma’s investor presentation at the H.C. Wainwright conference.
  • The presentation covers the company’s clinical program and activities.
  • Kairos Pharma planned to publish the presentation on its website.

Kairos Pharma, LTD. (AMEX: KAPA) issued a new investor presentation on September 14, 2026, for its participation in the H.C. Wainwright Global Investment Conference in New York, NY. Chief Executive Officer John Yu presented the material as part of the company’s conference participation.

Clinical Program Presentation Released

The presentation is intended to provide an update on Kairos Pharma’s clinical program and activities. The company planned to publish the material on its website, kairospharma.com. Kairos Pharma is incorporated in Delaware. The company issued the presentation in connection with its conference participation.